Articles
6 January 2004

Coffee Consumption and Risk for Type 2 Diabetes Mellitus

Publication: Annals of Internal Medicine
Volume 140, Number 1

Abstract

Background:

In small, short-term studies, acute administration of caffeine decreases insulin sensitivity and impairs glucose tolerance.

Objective:

To examine the long-term relationship between consumption of coffee and other caffeinated beverages and incidence of type 2 diabetes mellitus.

Design:

Prospective cohort study.

Setting:

The Nurses' Health Study and Health Professionals' Follow-up Study.

Participants:

The authors followed 41 934 men from 1986 to 1998 and 84 276 women from 1980 to 1998. These participants did not have diabetes, cancer, or cardiovascular disease at baseline.

Measurements:

Coffee consumption was assessed every 2 to 4 years through validated questionnaires.

Results:

The authors documented 1333 new cases of type 2 diabetes in men and 4085 new cases in women. The authors found an inverse association between coffee intake and type 2 diabetes after adjustment for age, body mass index, and other risk factors. The multivariate relative risks for diabetes according to regular coffee consumption categories (0, <1, 1 to 3, 4 to 5, or ≥ 6 cups per day) in men were 1.00, 0.98, 0.93, 0.71, and 0.46 (95% CI, 0.26 to 0.82; P = 0.007 for trend), respectively. The corresponding multivariate relative risks in women were 1.00, 1.16, 0.99, 0.70, and 0.71 (CI, 0.56 to 0.89; P < 0.001 for trend), respectively. For decaffeinated coffee, the multivariate relative risks comparing persons who drank 4 cups or more per day with nondrinkers were 0.74 (CI, 0.48 to 1.12) for men and 0.85 (CI, 0.61 to 1.17) for women. Total caffeine intake from coffee and other sources was associated with a statistically significantly lower risk for diabetes in both men and women.

Conclusions:

These data suggest that long-term coffee consumption is associated with a statistically significantly lower risk for type 2 diabetes.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Harris MIFlegal KMCowie CCEberhardt MSGoldstein DELittle RRet al . 1998 Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 21:518-24. [PMID: 9571335]
2.
Hu FBManson JEStampfer MJColditz GLiu SSolomon CGet al . Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790-7. [PMID: 11556298]
3.
Keijzers GBDe Galan BETack CJSmits P. Caffeine can decrease insulin sensitivity in humans. Diabetes Care. 2002;25:364-9. [PMID: 11815511]
4.
Lundsberg LS. Coffeine consumption. In: Spiller GA, eds. Caffeine. Boca Raton, FL: CRC Pr; 1998:199-224.
5.
Cheraskin ERingsdorf WM Jr. Blood-glucose levels after caffeine. Lancet. 1968;2:689. [PMID: 4175524]
6.
Feinberg LJSandberg HDe Castro OBellet S. Effects of coffee ingestion on oral glucose tolerance curves in normal human subjects. Metabolism. 1968;17:916-22. [PMID: 4300352]
7.
Graham TESathasivam PRowland MMarko NGreer FBattram D. Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test. Can J Physiol Pharmacol. 2001;79:559-65. [PMID: 11478588]
8.
Greer FHudson RRoss RGraham T. Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans. Diabetes. 2001;50:2349-54. [PMID: 11574419]
9.
Dulloo AGGeissler CAHorton TCollins AMiller DS. Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am J Clin Nutr. 1989;49:44-50. [PMID: 2912010]
10.
Astrup AToubro SCannon SHein PBreum LMadsen J. Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr. 1990;51:759-67. [PMID: 2333832]
11.
Bracco DFerrarra JMArnaud MJJequier ESchutz Y. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am J Physiol. 1995;269:671-8. [PMID: 7485480]
12.
Robertson DWade DWorkman RWoosley RLOates JA. Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest. 1981;67:1111-7. [PMID: 7009653]
13.
van Dam RMFeskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. Lancet. 2002;360:1477-8. [PMID: 12433517]
14.
Grobbee DERimm EBGiovannucci EColditz GStampfer MWillett W. Coffee, caffeine, and cardiovascular disease in men. N Engl J Med. 1990;323:1026-32. [PMID: 2215561]
15.
Colditz GAManson JEHankinson SE. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health. 1997;6:49-62. [PMID: 9065374]
16.
Salvini SHunter DJSampson LStampfer MJColditz GARosner BWillett WC. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol. 1989;18:858-67. [PMID: 2621022]
17.
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes. 1979;28:1039-57. [PMID: 510803]
18.
Manson JEColditz GAStampfer MJWillett WCKrolewski ASRosner Bet al . A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991;151:1141-7. [PMID: 2043016]
19.
Field AECoakley EHMust ASpadano JLLaird NDietz WHet al . Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581-6. [PMID: 11434789]
20.
Cox DROakes D. Analysis of Survival Data. London: Chapman and Hall; 1984.
21.
Salmeron JManson JEStampfer MJColditz GAWing ALWillett WC. Dietary fiber, glycemic load, and risk of non–insulin-dependent diabetes mellitus in women. JAMA. 1997;277:472-7. [PMID: 9020271]
22.
Hu FBStampfer MJManson JERimm EColditz GARosner BAet al . Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997;337:1491-9. [PMID: 9366580]
23.
Thong FSGraham TE. Caffeine-induced impairment of glucose tolerance is abolished by β-adrenergic receptor blockade in humans. J Appl Physiol. 2002;92:2347-52. [PMID: 12015346]
24.
Brown CRBenowitz NL. Caffeine and cigarette smoking: behavioral, cardiovascular, and metabolic interactions. Pharmacol Biochem Behav. 1989;34:565-70. [PMID: 2623013]
25.
Spriet LLMacLean DADyck DJHultman ECederblad GGraham TE. Caffeine ingestion and muscle metabolism during prolonged exercise in humans. Am J Physiol. 1992;262:891-8. [PMID: 1616022]
26.
Ryu SChoi SKJoung SSSuh HCha YSLee Set al . Caffeine as a lipolytic food component increases endurance performance in rats and athletes. J Nutr Sci Vitaminol Tokyo. 2001;47:139-46. [PMID: 11508705]
27.
Ramsey JJColman RJSwick AGKemnitz JW. Energy expenditure, body composition, and glucose metabolism in lean and obese rhesus monkeys treated with ephedrine and caffeine. Am J Clin Nutr. 1998;68:42-51. [PMID: 9665095]
28.
Astrup ABreum LToubro SHein PQuaade F. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int J Obes Relat Metab Disord. 1992;16:269-77. [PMID: 1318281]
29.
Boozer CNDaly PAHomel PSolomon JLBlanchard DNasser JAet al . Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord. 2002;26:593-604. [PMID: 12032741]
30.
Devasagayam TPKamat JPMohan HKesavan PC. Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species. Biochim Biophys Acta. 1996;1282:63-70. [PMID: 8679661]
31.
Meyer KAKushi LHJacobs DR JrSlavin JSellers TAFolsom AR. Carbohydrates, dietary fiber, and incident type 2 diabetes in older women. Am J Clin Nutr. 2000;71:921-30. [PMID: 10731498]

Comments

0 Comments
Sign In to Submit A Comment

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 140Number 16 January 2004
Pages: 1 - 8

History

Published online: 6 January 2004
Published in issue: 6 January 2004

Keywords

Authors

Affiliations

Eduardo Salazar-Martinez, MD, PhD
From Harvard School of Public Health, Channing Laboratory, Harvard Medical School, and Brigham and Women's Hospital, Boston, Massachusetts; and Mexican Institute of Social Security, Cuernavaca, Morelos, Mexico.
Walter C. Willett, MD, DrPH
From Harvard School of Public Health, Channing Laboratory, Harvard Medical School, and Brigham and Women's Hospital, Boston, Massachusetts; and Mexican Institute of Social Security, Cuernavaca, Morelos, Mexico.
Alberto Ascherio, MD, DrPH
From Harvard School of Public Health, Channing Laboratory, Harvard Medical School, and Brigham and Women's Hospital, Boston, Massachusetts; and Mexican Institute of Social Security, Cuernavaca, Morelos, Mexico.
JoAnn E. Manson, MD, DrPH
From Harvard School of Public Health, Channing Laboratory, Harvard Medical School, and Brigham and Women's Hospital, Boston, Massachusetts; and Mexican Institute of Social Security, Cuernavaca, Morelos, Mexico.
Michael F. Leitzmann, MD, DrPH
From Harvard School of Public Health, Channing Laboratory, Harvard Medical School, and Brigham and Women's Hospital, Boston, Massachusetts; and Mexican Institute of Social Security, Cuernavaca, Morelos, Mexico.
Meir J. Stampfer, MD, DrPH
From Harvard School of Public Health, Channing Laboratory, Harvard Medical School, and Brigham and Women's Hospital, Boston, Massachusetts; and Mexican Institute of Social Security, Cuernavaca, Morelos, Mexico.
Frank B. Hu, MD, PhD
From Harvard School of Public Health, Channing Laboratory, Harvard Medical School, and Brigham and Women's Hospital, Boston, Massachusetts; and Mexican Institute of Social Security, Cuernavaca, Morelos, Mexico.
Acknowledgments: The authors thank Tricia Li for her expert assistance in data analysis.
Grant Support: By research grants DK58845, HL35464, AA11181, CA87969, and CA55075 from the National Institutes of Health.
Disclosures: None disclosed.
Corresponding Author: Frank B. Hu, MD, PhD, Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115; e-mail, [email protected].
Current Author Addresses: Dr. Salazar-Martinez: National Institute of Public Health, Av. Universidad 655, Col. Sta. Maria Ahuacatitlánin, 62508 Cuernavaca, Morelos, Mexico.
Drs. Willett, Ascherio, and Hu: Department of Nutrition, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115.
Dr. Manson: Division of Preventive Medicine, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, 900 Commonwealth Avenue, 3rd Floor, Boston, MA 02215.
Dr. Leitzmann: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MSC 7232, Bethesda, MD 20892.
Dr. Stampfer: Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115.
Author Contributions: Conception and design: E. Salazar-Martinez, W.C. Willett, A. Ascherio, J.E. Manson, M.F. Leitzmann, F.B. Hu.
Analysis and interpretation of the data: E. Salazar-Martinez, W.C. Willett, A. Ascherio, J.E. Manson, M.F. Leitzmann, M.J. Stampfer, F.B. Hu.
Drafting of the article: E. Salazar-Martinez, F.B. Hu.
Critical revision of the article for important intellectual content: E. Salazar-Martinez, W.C. Willett, A. Ascherio, J.E. Manson, M.F. Leitzmann, M.J. Stampfer, F.B. Hu.
Final approval of the article: E. Salazar-Martinez, A. Ascherio, J.E. Manson, M.F. Leitzmann, M.J. Stampfer, F.B. Hu.
Statistical expertise: M.F. Leitzmann, M.J. Stampfer, F.B. Hu.
Obtaining of funding: W.C. Willett, J.E. Manson, F.B. Hu.
Administrative, technical, or logistic support: J.E. Manson, F.B. Hu.
Collection and assembly of data: J.E. Manson, F.B. Hu.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Eduardo Salazar-Martinez, Walter C. Willett, Alberto Ascherio, et al. Coffee Consumption and Risk for Type 2 Diabetes Mellitus. Ann Intern Med.2004;140:1-8. [Epub 6 January 2004]. doi:10.7326/0003-4819-140-1-200401060-00005

View More

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Access to EPUBs and PDFs for FREE Annals content requires users to be registered and logged in. A subscription is not required. You can create a free account below or from the following link. You will be redirected to acponline.org to create an account that will provide access to Annals. If you are accessing the Free Annals content via your institution's access, registration is not required.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/EPUB

View PDF/EPUB

Related in ACP Journals

Full Text

View Full Text

Figures

Tables

Media

Share

Share

Copy the content Link

Share on social media